Related Experiment Video
Updated: Apr 15, 2026

09:25
Rapid, Seamless Generation of Recombinant Poxviruses using Host Range and Visual Selection
Published on: May 24, 2020
5.9K
Semliki forest virus-based expression of recombinant GPCRs
1PanTherapeutics, Lutry, Switzerland.
Methods in Enzymology
|April 11, 2015
Summary
Recombinant Semliki Forest virus (SFV) enables rapid, high-level production of G protein-coupled receptors (GPCRs) for drug discovery. This method facilitates parallel studies, purification, structural analysis, and in vivo research.
Area of Science:
- Biochemistry
- Molecular Biology
- Neuroscience
Background:
- G protein-coupled receptors (GPCRs) are crucial drug targets.
- Efficient production of GPCRs is essential for drug discovery.
- Existing methods for GPCR production can be limiting.
Purpose of the Study:
- To establish a rapid and high-level production system for GPCRs.
- To enable comprehensive pharmacological and structural characterization of GPCRs.
- To facilitate in vivo studies of GPCRs using neuronal delivery.
Main Methods:
- Utilized recombinant Semliki Forest virus (SFV) particles for GPCR expression.
- Employed various mammalian host cell lines (adherent and suspension cultures).
- Applied SFV for neuronal delivery to primary neurons and hippocampal slice cultures.
Main Results:
- Achieved rapid, high-titer production of functional GPCRs.
- Enabled parallel pharmacological characterization (binding and functional coupling).
- Facilitated large-scale GPCR production for purification and structural studies.
- Demonstrated successful in vivo functional and localization studies in neuronal systems.
Conclusions:
- Recombinant SFV is a versatile tool for GPCR production and characterization.
- This system accelerates drug discovery by enabling parallel and large-scale studies.
- SFV-mediated expression and delivery are effective for studying GPCRs in complex biological systems.

